As of 2025-09-18, the Fair Value of Oric Pharmaceuticals Inc (ORIC) is -7.05 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.52 USD, the upside of Oric Pharmaceuticals Inc is -167.05%.
With the market price of 10.52 USD and our fair value calculation, Oric Pharmaceuticals Inc (ORIC) is not a good investment. Investing in ORIC stocks now will result in a potential loss of 167.05%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -73.70 | -78.72 | -89.12 | -101.00 | -128.00 | -94.11 |
| YoY growth | -174.18% | -6.81% | -13.21% | -13.33% | -26.73% | -46.85% |
| Market Cap (mil) | 1,021.70 |
| P/E | |
| Forward P/E |
| EPS | -1.41 |
| Avg earnings growth rate | -46.85% |
| TTM earnings | -137.00 |